Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor

Journal of Neuroscience Research

Volumn 77, Issue 2, 2004, Pages 250-257

  Züchner, Thole ^a   Perez Polo, J Regino ^b   Schliebs, Reinhard ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

amyloid; Beta secretase; Immunoblot; Muscarinic receptor; SY5Y cells

Indexed keywords

AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC M1 RECEPTOR AGONIST; MUSCARINIC RECEPTOR; PHORBOL ESTER; PROTEIN KINASE C; TALSACLIDINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CELL LINE; CHOLINERGIC ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; UPREGULATION;

ADENYLATE CYCLASE; ALZHEIMER DISEASE; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; BRAIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MUSCARINIC AGONISTS; NEURONS; PHORBOL ESTERS; PROTEIN KINASE C; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; TREATMENT FAILURE; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 3042712380     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20152     Document Type: Article

References (39)

1. Bigl V, Rossner S. 2003. Amyloid precursor protein processing in vivo-insights from a chemically induced constitutive overactivation of protein kinase C in guinea pig brain. Curr Med Chem 10:871-882.
2. Bigl M, Apelt J, Luschekina EA, Lange-Dohna C, Rossner S, Schliebs R. 2000. Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology. Neurosci Lett 292:107-110.
3. Canet-Aviles RM, Anderton M, Hooper NM, Turner AJ, Vaughan PF. 2002. Muscarine enhances soluble amyloid precursor protein secretion in human neuroblastoma SH-SY5Y by a pathway dependent on protein kinase Calpha, src-tyrosine kinase and extracellular signal-regulated kinase but not phosphlipase C. Brain Res Mol Brain Res 102:62-72.
4. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-p-bromocinnamylaminoethyl]-5- isoquinolinesulfonamide H-89, of PC12D pheochromocytoma cells. J Biol Chem 65:5267-5272.
5. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade Proc Natl Acad Sci USA 92:7686-7689.
6. Ensinger HA, Doods HN, Immel-Sehr AR, Kuhn FJ, Lambrecht G, Mendla KD, Muller RE, Mutschler E, Sagrada A, Walther G. 1993. WAL 2014 - a muscarinic agonist with preferential neuron-stimulating properties. Life Sci 52:473-480.
7. Farber SA, Nitsch RM, Schulz JG, Wurtman RJ. 1995. Regulated secretion of beta-amyloid precursor protein in rat brain. J Neurosci 15:7442-7451.
8. Giacobini E, Zhu XD, Williams E, Sherman KA. 1996. The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex. Neuropharmacology 35:205-211.
9. Harrison SM, Harper AJ, Hawkins J, Duddy G, Grau E, Pugh PL, Winter PH, Shilliam CS, Hughes ZA, Dawson LA, Gonzalez MI, Upton N, Pangalos MN, Dingwall C. 2003. BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changes. Mol Cell Neurosci 24:646-655.
10. Hong HS, Hwang EM, Sim HJ, Cho HJ, Boo JH, Oh SS, Kim SU, Mook-Jung I. 2003. Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes. Biochem Biophys Res Commun 307:922-927.
11. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS, Murphy KE, Southan CD, Ryan DM, Smith TS, Simmons DL, Walsh FS, Dingwall C, Christie G. 1999. Identification of a novel aspartic protease Asp 2 as beta-secretase. Mol Cell Neurosci 14:419-427.
12. ++ mobilization and northern blotting. J Pharmacol Exp Ther 263:1487-1493.
13. Lambert DG, Ghataorre AS, Nahorski SR. 1989. Muscarinic receptor binding characteristics of a human neuroblastoma SK-N-SH and its clones SH-SY5Y and SH-EP1. Eur J Pharmacol 165:71-77.
14. Lange-Dohna C, Zeitschel U, Gaunitz F, Perez-Polo JR, Bigl V, Rossner S. 2003. Cloning and expression of the rat BACE1-1 promoter. J Neurosci Res 73:73-80.
15. Lowry O, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
16. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis JC, Yan Q, Richards WG, Citron M, Vassar R. 2001. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 4:231-232.
17. Mazzucchelli M, Porrello E, Villetti G, Pietra C, Govoni S, Racchi M. 2003. Characterization of the effect of ganstigmine CHF2819 on amyloid precursor protein metabolism in SH-SY5Y neuroblastoma cells. J Neural Transm 110:935-947.
18. Mori F, Lai CC, Fusi F, Giacobini E. 1995. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neuroreport 6:633-636.
19. Murphy NP, Vaughan PF, Ball SG, McCormack JG. 1991. The cholinergic regulation of intracellular calcium in the human neuroblastoma, SH-SY5Y. J Neurochem 57:2116-2123.
20. Murray JN, Igwe OJ. 2003. Regulation of beta-amyloid precursor protein and inositol 1,4,5-trisphosphate receptor gene expression during differentiation of a human neuronal cell-line. Prog Neuropsychopharmacol Biol Psychiatry 27:351-363.
21. Nitsch RM, Growdon JH. 1994. Role of neurotransmission in the regulation of amyloid beta-protein precursor processing. Biochem Pharmacol 47:1275-1284.
22. Nitsch RM, Slack BE, Farber SA, Schulz JG, Deng M, Kim C, Borghesani PR, Korver W, Wurtman RJ, Growdon JH. 1994. Regulation of proteolytic processing of the amyloid beta-protein precursor of Alzheimer's disease in transfected cell lines and in brain slices. J Neural Transm Suppl 44:21-27.
23. Pakaski M, Papp H, Rakonczay Z, Fakla I, Kasa P. 1998. Effects of acetylcholinesterase inhibitors on the metabolism of amyloid precursor protein in vitro. Neurobiology 9:55-57.
24. Parvathy S, Hussain I, Karran EH, Turner AJ, Hooper NM. 1998. Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 37:1680-1685.
25. Piazzi L, Rampa A, Bisi A, Gobbi S, Belluti F, Cavalli A, Bartolini M, Andrisano V, Valenti P, Recanatini M. 2003. 3-(4-[[Benzyl(methyl)amino]methyl] phenyl)6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation: a dual function lead for Alzheimer's disease therapy. J Med Chem 45:2279-2283.
26. Racchi M, Mazzucchelli M, Pascale A, Sironi M, Govoni S. 2003. Role of protein kinase C in the regulated secretion of the amyloid precursor protein. Mol Psychiatry 8:209-216.
27. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, Freedman SB, Frigon NL, Games D, Hu K, Johnson-Wood K, Kappenman KE, Kawabe TT, Kola I, Kuehn R, Lee M, Liu W, Motter R, Nichols NF, Power M, Robertson DW, Schenk D, Schoor M, Shopp GM, Shuck ME, Sinha S, Svensson KA, Tatsuno G, Tintrup H, Wijsman J, Wright S, McConlogue L. 2001. BACE1 knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 10:1317-1324.
28. 2+]. Brain Res Mol Brain Res 87:81-91.
29. Rossner S, Bakinde N, Zeitschel U, Schliebs R, Bigl V. 1998. Cerebrospinal fluid cholinesterases - markers for loss of cholinergic basal forebrain neurons?. Int J Dev Neurosci 16:669-673.
30. Rossner S, Apelt J, Schliebs R, Perez-Polo JR, Bigl V. 2001. Neuronal and glial beta-secretase BACE1 protein expression in transgenic Tg2576 mice with amyloid plaque pathology. J Neurosci Res 64:437-446.
31. Seamon KB, Daly JW. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J Cyclic Nucleotide Res 7:201-224.
32. Selkoe DJ. 2002. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease. J Clin Invest 110:1375-1381.
33. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M, Dovey HF, Frigon N, Hong J, Jacobson-Croak K, Jewett N, Keim P, Knops J, Lieberburg I, Power M, Tan H, Tatsuno G, Tung J, Schenk D, Seubert P, Suomensaari SM, Wang S, Walker D, John V. 1999. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402:471-472.
34. Solano DC, Sironi M, Bonfini C, Solerte SB, Govoni S, Racchi M. 2000. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J 14:1015-1022.
35. Tamagno E, Bardini P, Obbili A, Vitali A, Borghi K, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M. 2002. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10:279-288.
36. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. 1999. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE1. Science 286:735-741.
37. Vaughan PF, Walker JH, Peers C. 1998. The regulation of neurotransmitter secretion by protein kinase C. Mol Neurobiol 18:125-155.
38. 3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Life Sci 32:3001-3011.
39. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashier JR, Stratman NC, Mathews WR, Buhl AE, Carter DB, Tomasselli AG, Parodi LA, Heinrikson RL, Gurney ME. 1999. Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402:533-537.